Apple is preparing to raise the prices of its next iPhone lineup, expected to launch this autumn.
The decision, though driven partly by high costs of operations and redesign initiative, is due to trade issues between the United States and China.
Multiple people familiar with Apple’s supply chain confirmed that while the company intends to justify the price jump with upgrades in design and functionality, there are internal concerns about public complaints on the increases seen as a direct result of the ongoing tariff fight.
Apple faces a potential $900 million tariff-related expense this quarter alone. But it’s not talking. There’s been no official word from the company confirming whether these costs will be passed on to customers. Yet the timing tells us something.
To manage the issue, Apple has been shifting more of its production to India, especially for the standard iPhone models. But high-end units like the Pro and Pro Max are still largely made in China.
India, while emerging as a promising base, lacks the technical depth and infrastructure to handle production of Apple’s most advanced devices. A complete transition, according to insiders, is not realistic before 2027.
In an earlier announcement, U.S. and Chinese officials agreed to suspend reciprocal tariffs for 90 days to allow more room for dialogue. Despite this pause, a 20% tariff on Chinese imports remains, and Apple continues to be exposed.
Recent concessions by the Trump administration offer some relief for tech manufacturers, exempting smartphones, laptops, and essential components, but the risk to Apple’s supply chain is still obvious.
Apple’s design vision is also evolving. This year, reports reveal the company will release an ultra-thin iPhone. But the bigger leap is set for 2027, Apple’s 20th iPhone anniversary.
Bloomberg reported that Apple is developing a “mostly glass, curved iPhone” with no cutouts. It’s a great design that would show the company’s radical move in 2017 with the iPhone X.
There’s no question that Apple is facing a complex balancing act. On one hand, it must invest in innovation to maintain its premium appeal. On the other, it is fighting to avoid consumer blowback from higher prices triggered by global trade policies.
A senior U.S. official, Treasury Secretary Scott Bessent, noted after the recent trade talks: “We had a very robust and productive discussion on steps forward on fentanyl. We are in agreement that neither side wants to decouple.”
